Press Release | September 17, 2024
āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors
Read More
News | September 12, 2024
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
Read More
Press Release | September 3, 2024
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
Read More
Press Release | August 14, 2024
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
Read More
